Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Journal of Cellular and Molecular Medicine
|
October 28, 2020
The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation
Claudia Dafinger, Amrei M Mandel, Alina Braun, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2022
Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression
Masaw Akbari, Jonathan D West, Nicholas Doerr, et al.
Plos One
|
August 26, 2016
Regulation of Polycystin-1 Function by Calmodulin Binding
Nicholas Doerr, Yidi Wang, Kevin R Kipp, et al.
Journal of the American Society of Nephrology : JASN
|
January 21, 2026
Correction to: Kidney Week 2025 Abstract Three-Month Interim Analysis of Ketogenic Metabolic Therapy in Japanese Patients with ADPKD SA-PO0579
Haruna Kawano, Wakana Koizumi, Yan Lu, et al.
The Journal of Clinical Investigation
|
May 1, 2025
Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease
Jacob A Torres, Mina Rezaei, Caroline Broderick, et al.
The Journal of Clinical Investigation
|
July 31, 2019
Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease
Jacob A Torres, Mina Rezaei, Caroline Broderick, et al.
Clinical Kidney Journal
|
June 6, 2022
Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects
Sebastian Strubl, Simon Oehm, Jacob A Torres, et al.
Iscience
|
September 24, 2024
β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease
Jacob A Torres, Nickolas Holznecht, David A Asplund, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 29, 2006
The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease
Jonathan M Shillingford, Noel S Murcia, Claire H Larson, et al.
Cell Reports. Medicine
|
November 7, 2023
Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial
Sadrija Cukoski, Christoph Heinrich Lindemann, Sita Arjune, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Journal of Cellular and Molecular Medicine
|
October 28, 2020
The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation
Claudia Dafinger, Amrei M Mandel, Alina Braun, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2022
Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression
Masaw Akbari, Jonathan D West, Nicholas Doerr, et al.
Plos One
|
August 26, 2016
Regulation of Polycystin-1 Function by Calmodulin Binding
Nicholas Doerr, Yidi Wang, Kevin R Kipp, et al.
Journal of the American Society of Nephrology : JASN
|
January 21, 2026
Correction to: Kidney Week 2025 Abstract Three-Month Interim Analysis of Ketogenic Metabolic Therapy in Japanese Patients with ADPKD SA-PO0579
Haruna Kawano, Wakana Koizumi, Yan Lu, et al.
The Journal of Clinical Investigation
|
May 1, 2025
Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease
Jacob A Torres, Mina Rezaei, Caroline Broderick, et al.
The Journal of Clinical Investigation
|
July 31, 2019
Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease
Jacob A Torres, Mina Rezaei, Caroline Broderick, et al.
Clinical Kidney Journal
|
June 6, 2022
Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects
Sebastian Strubl, Simon Oehm, Jacob A Torres, et al.
Iscience
|
September 24, 2024
β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease
Jacob A Torres, Nickolas Holznecht, David A Asplund, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 29, 2006
The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease
Jonathan M Shillingford, Noel S Murcia, Claire H Larson, et al.
Cell Reports. Medicine
|
November 7, 2023
Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial
Sadrija Cukoski, Christoph Heinrich Lindemann, Sita Arjune, et al.
Page
of 8